Logos Global Management LP 13D and 13G filings for Tenax Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-05-15 6:55 pm Purchase | 2026-03-31 | 13G | TENAX THERAPEUTICS INC PAR TENX | Logos Global Management LP | 800,000 3.000% | 185,000 (+30.08%) | Filing |
| 2026-03-09 12:24 pm Purchase | 2026-02-27 | 13G | TENAX THERAPEUTICS INC PAR TENX | Logos Global Management LP | 615,000 9.900% | 615,000 (New Position) | Filing |